Inventor · disambiguated record
Laurie B. Schenkel
Also filed as: SCHENKEL LAURIE · SCHENKEL LAURIE B
26 granted patents·15 pending applications·148 citations·filing 2008–2025
96Inventor score
Files withRIBON THERAPEUTICS INC20AMGEN INC11BOEHRINGER INGELHEIM INT3TEIJIN PHARMA LTD2BO YUNXIN Y1
Top patents by PatentIndex Score
41 records- 0197US11014913B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2020·Granted May 25, 2021·6 cites·13 claims
- 0297US10550105B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·13 cites·8 claims
- 0395US11566020B1Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2021·Granted Jan 31, 2023·3 cites·26 claims
- 0495US9663508B2Biaryl acyl-sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted May 30, 2017·29 cites·20 claims
- 0594US10870641B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·6 cites·30 claims
- 0693US11535621B2Heterobicyclic amides as inhibitors of CD38RIBON THERAPEUTICS INC·Filed 2020·Granted Dec 27, 2022·3 cites·4 claims
- 0792US11987584B2Heterobicyclic amides as inhibitors of CD38RIBON THERAPEUTICS INC·Filed 2022·Granted May 21, 2024·1 cites·22 claims
- 0892US10562891B2Quinazolinones as PARP14 inhibitorsRIBON THERAPEUTICS INC·Filed 2018·Granted Feb 18, 2020·5 cites·4 claims
- 0992US7928140B2Benzothiazole PI3 kinase modulators for cancer treatmentAMGEN INC·Filed 2008·Granted Apr 19, 2011·32 cites·17 claims
- 1089US11952377B2Quinolines and azaquinolines as inhibitors of CD38BOEHRINGER INGELHEIM INT·Filed 2022·Granted Apr 9, 2024·1 cites·9 claims
- 1189US11293927B2Screening methods for PARP modulatorsRIBON THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·3 cites·14 claims
- 1288US8022221B2Aurora kinase modulators and method of useAMGEN INC·Filed 2009·Granted Sep 20, 2011·10 cites·28 claims
- 1387US7776857B2Aurora kinase modulators and method of useAMGEN INC·Filed 2008·Granted Aug 17, 2010·10 cites·17 claims
- 1486US2025034120A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1583US12398146B2Heterobicyclic amides as inhibitors of CD38BOEHRINGER INGELHEIM INT·Filed 2024·Granted Aug 26, 2025·0 cites·53 claims
- 1682US12371421B2Solid forms of a PARP7 inhibitorRIBON THERAPEUTICS INC·Filed 2020·Granted Jul 29, 2025·1 cites·20 claims
- 1782US11008308B2Quinazolinones as PARP14 inhibitorsRIBON THERAPEUTICS INC·Filed 2020·Granted May 18, 2021·1 cites·2 claims
- 1882US8686155B2Aurora kinase modulators and method of useCEE VICTOR J·Filed 2011·Granted Apr 1, 2014·8 cites·19 claims
- 1982US7981891B2Aurora kinase modulators and method of useAMGEN INC·Filed 2010·Granted Jul 19, 2011·7 cites·12 claims
- 2082US2025020654A1Screening methods for parp modulatorsRIBON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2180US9556135B2Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Granted Jan 31, 2017·2 cites·38 claims
- 2280US2023192664A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2379US11332459B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2018·Granted May 17, 2022·2 cites·16 claims
- 2476US2025074897A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2575US9096615B2Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereofAMGEN INC·Filed 2014·Granted Aug 4, 2015·2 cites·32 claims
- 2674US2024279224A1Quinolines and azaquinolines as inhibitors of cd38BOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2773US2022206008A1Screening methods for parp modulatorsRIBON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2870US8415376B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2009·Granted Apr 9, 2013·1 cites·9 claims
- 2969US8557816B2Aurora kinase modulators and method of useGEUNS-MEYER STEPHANIE·Filed 2011·Granted Oct 15, 2013·2 cites·9 claims
- 3068US11958837B2Quinazolinones as PARP14 inhibitorsRIBON THERAPEUTICS INC·Filed 2021·Granted Apr 16, 2024·0 cites·46 claims
- 3161US2024190844A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3261US2023303542A1Solid forms of a parp14 inhibitorRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3359US2022265655A1Methods of treating inflammatory diseasesRIBON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3458US2014107109A1Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 3550US2022388985A1Targeted protein degradation of parp14 for use in therapyRIBON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3645US12492185B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2020·Granted Dec 9, 2025·0 cites·5 claims
- 3745US2025346600A1Tricyclic derivatives and related usesMOMA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3844US2014336182A1Aurora Kinase Modulators and Method of UseAMGEN INC·Filed 2013·Application pending·0 cites
- 3943US9309263B2Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereofAMGEN INC·Filed 2014·Granted Apr 12, 2016·0 cites·31 claims
- 4042US2015252059A1Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereofAMGEN INC·Filed 2015·Application pending·0 cites
- 4134US2012165334A1Indole/Benzimidazole Compounds as mTOR Kinase InhibitorsBOEZIO ALESSANDRO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurie B. Schenkel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →